The objective of this paper is to estimate the association between multiple sclerosis (MS) and measures of sun exposure in specific age periods in Norway and Italy.
Methods:
A total of 1660 MS patients and 3050 controls from Italy and Norway who participated in a multinational case-control study (EnvIMS) reported sun habits during childhood and adolescence.
Results:
A significant association between infrequent summer outdoor activity and increased MS risk was found in Norway and in Italy. The association was strongest between the ages of 16 and 18 years in Norway (odds ratio (OR) 1.83, 95% confidence interval (CI) 1.30–2.59), and between birth and age 5 years in Italy (OR 1.56, 95% CI 1.16–2.10). In Italy a significant association was also found during winter (OR 1.42, 95% CI 1.03–1.97). Frequent sunscreen use between birth and the age of 6 years was associated with MS in Norway (OR 1.44, 95% CI 1.08–1.93) after adjusting for outdoor activity during the same period. Red hair (OR 1.67, 95% CI 1.06–2.63) and blonde hair (OR 1.36, 95% CI 1.09–1.70) were associated with MS after adjusting for outdoor activity and sunscreen use.
Conclusion:
Converging evidence from different measures underlines the beneficial effect of sun exposure on MS risk.
HandelAEHandunnetthiLGiovannoniG. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol2010; 17: 1210–1214.
2.
van der MeiIAPonsonbyALBlizzardL. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology2001; 20: 168–174.
3.
AscherioAMungerKLSimonKC. Vitamin D and multiple sclerosis. Lancet Neurol2010; 9: 599–612.
4.
GarssenJvan LoverenH. Effects of ultraviolet exposure on the immune system. Crit Rev Immunol2001; 21: 359–397.
5.
HayesCECantornaMTDeLucaHF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med1997; 216: 21–27.
6.
StaplesJPonsonbyALLimL. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis. BMJ2010; 340: c1640.
7.
IslamTGaudermanWJCozenW. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology2007; 69: 381–388.
8.
van der MeiIAPonsonbyALDwyerT. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ2003; 327: 316.
9.
KampmanMTWilsgaardTMellgrenSI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol2007; 254: 471–477.
10.
MungerKLLevinLIHollisBW. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006; 296: 2832–2838.
11.
SalzerJHallmansGNyströmM. Vitamin D as a protective factor in multiple sclerosis. Neurology2012; 79: 2140–2145.
12.
GoodinDS. The causal cascade to multiple sclerosis: A model for MS pathogenesis. PLoS One2009; 4: e4565.
13.
MungerKLLevinLIMassaJ. Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. Am J Epidemiol2013; 177: 411–419.
14.
EngelsenO. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients2010; 2: 482–495.
15.
HolmøyTTorkildsenØMyhrKM. Vitamin D supplementation and monitoring in multiple sclerosis: Who, when and wherefore. Acta Neurol Scand Suppl2012: 63–69.
16.
González-GrossMValtueñaJBreidenasselC. Vitamin D status among adolescents in Europe: The Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br J Nutr2012; 107: 755–764.
17.
PugliattiMCasettaIDrulovicJ. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl2012: 43–50.
18.
RiiseTWolfsonC. The epidemiologic study of exogenous factors in the etiology of multiple sclerosis – Guidelines for future analytical research – Preface. Neurology1997; 49: S1–SS.
19.
GranieriECasettaIGovoniV. The increasing incidence and prevalence of MS in a Sardinian province. Neurology2000; 55: 842–848.
20.
GranieriEEconomouNTDe GennaroR. Multiple sclerosis in the province of Ferrara: Evidence for an increasing trend. J Neurol2007; 254: 1642–1648.
21.
GranieriEMonaldiniCDe GennaroR. Multiple sclerosis in the Republic of San Marino: A prevalence and incidence study. Mult Scler2008; 14: 325–329.
22.
MidgardR. Incidence and prevalence of multiple sclerosis in Norway. Acta Neurol Scand Suppl2012: 36–42.
23.
MyhrKMGryttenNAarsethJH. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand Suppl2012: 20–23.
24.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
FaurschouABeyerDMSchmedesA. The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: A randomized clinical trial. Br J Dermatol2012; 167: 391–395.
27.
LucasRMPonsonbyALDearK. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology2011; 76: 540–548.
28.
TassoneFGianottiLBaffoniC. Vitamin D status in primary hyperparathyroidism: A Southern European perspective. Clin Endocrinol (Oxf). Epub ahead of print 23March2013.
29.
AutierPDoreJFNegrierS. Sunscreen use and duration of sun exposure: A double-blind, randomized trial. J Natl Cancer Inst1999; 91: 1304–1309.
30.
DwyerTvan der MeiIPonsonbyAL. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology2008; 71: 583–589.
31.
RiiseTKirkeleitJAarsethJH. Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Mult Scler2011; 17: 780–787.
32.
CicarmaEPorojnicuACLagunovaZ. Sun and sun beds: Inducers of vitamin D and skin cancer. Anticancer Res2009; 29: 3495–3500.
